Recent News

For University of Vermont-related news, see below. For MaineHealth news, click here.

Gilbert Speaks to iNews about ‘Off-Label’ Use of Ozempic to Lose Weight

July 10, 2023 by Lucy Gardner Carson

(JULY 10, 2023) Endocrinologist Matthew Gilbert, M.D., professor of medicine, told iNews the surging demand for the diabetes drug Ozempic as an “off-label” weight-loss drug “is a good example of social media driving demand for a product that is effective.”

Endocrinologist Matthew Gilbert, M.D., professor of medicine

(JULY 10, 2023) Speaking to iNews about the surging demand for Ozempic — a drug that is approved by the FDA to treat people with diabetes but which, in “off-label” use, leads a weight-loss drug market worth $2 billion — endocrinologist Matthew Gilbert, M.D., professor of medicine says, “This is a good example of social media driving demand for a product that is effective.”

Ozempic, Gilbert says, is among a handful of drugs that mimic natural hormones to trigger the body’s release of insulin, which is critical to combatting diabetes. Since its development in 2012 by Novo Nordisk, it has been shown to suppress appetite and slow the movement of food through the stomach, leading to people losing more than 10 percent of their body weight. Social media has exploded with stories of celebrities and regular people alike touting the effectiveness of a “magic pill” for dramatic and fast weight loss.

Despite some doctors’ concerns that the surge in popularity of weight-loss drugs is “troubling” — potential side-effects of using Ozempic include diarrhea, abdominal pain, constipation, and the sagging and aging of facial skin as the result of rapid weight loss — many doctors praise the role played by Ozempic and other drugs in helping treat obesity.

This topic was also reported in a story on WCAX-TV and other media.

Read full story at iNews

Want to be our next news story?

Have you started a cool new project? Published a paper? Won an award? We want to hear from you! Contact us to be highlighted on our website, in our newsletters, and/or in our press releases.

Check out our newsletter archive:

December 2021

March 2022

August 2022


June 2023

Fall 2023

Winter 2024

Spring 2024

Summer 2024


Please email us with any questions or for assistance accessing services.

Become a Member

All NNE-CTR members have access to our services and support. Learn more about the free benefits of membership, and join today!